Transcode Therapeutics, Inc.
RNAZNasdaqCIK 1829635HealthcareFiscal year ends Dec 31
Reports and events: 150 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0120:05 ET | 8-K | 1.01 Entry into a material agreement; 2.04 Item not in the standard list | 0001104659-26-112826 |
| 2026-09-2812:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-111170 |
| 2026-09-1121:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-107115 |
| 2026-08-1421:05 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001829635-26-000003 |
| 2026-08-0320:38 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-089819 |
| 2026-08-0320:15 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-26-089805 |
| 2026-07-2720:15 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-087098 |
| 2026-07-2320:15 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-086266 |
| 2026-07-2020:15 ET | 8-K | 5.07 Shareholder vote results | 0001104659-26-085073 |
| 2026-07-1720:15 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-084636 |
| 2026-07-1720:05 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-26-084617 |
| 2026-07-0220:05 ET | 8-K | 8.01 Other events | 0001104659-26-080311 |
| 2026-06-1812:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-075440 |
| 2026-06-0312:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-069810 |
| 2026-06-0220:05 ET | DEF 14A | Proxy statementPeriod 2026-07-02 | 0001104659-26-069458 |
| 2026-06-0112:59 ET | 8-K | 5.08 Item not in the standard list | 0001104659-26-068647 |
| 2026-05-2610:43 ET | 8-K/A | 3.01 Delisting notice | 0001104659-26-065959 |
| 2026-05-2220:15 ET | 8-K | 3.01 Delisting notice | 0001104659-26-065728 |
| 2026-05-1520:10 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-062535 |
| 2026-05-0100:58 ET | S-1 | Registration statement | 0001104659-26-053289 |
| 2026-04-3020:15 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001104659-26-052941 |
| 2026-04-1520:17 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-043810 |
| 2026-04-0712:35 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-040171 |
| 2026-03-0321:05 ET | 8-K | 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-022830 |
| 2026-02-2313:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-018362 |
| 2026-02-0513:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-010668 |
| 2026-01-0613:04 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-001097 |
| 2025-12-2321:15 ET | 8-K/A | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-124226 |
| 2025-12-2213:13 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-123500 |
| 2025-12-1113:09 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-120146 |
| 2025-11-1421:03 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001829635-25-000004 |
| 2025-10-2821:39 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-103292 |
| 2025-10-2713:03 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-25-102361 |
| 2025-10-1721:09 ET | 8-K/A | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-100456 |
| 2025-10-1620:05 ET | SCHEDULE 13D | Ownership report, active investor | 0001104659-25-100081 |
| 2025-10-1412:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-099029 |
| 2025-10-0820:13 ET | 8-K/A | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-097919 |
| 2025-10-0813:57 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-097799 |
| 2025-10-0320:15 ET | 8-K | 1.01 Entry into a material agreement | 0001104659-25-096658 |
| 2025-09-0221:07 ET | 8-K | 5.07 Shareholder vote results | 0001104659-25-086442 |
| 2025-08-1420:15 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-011571 |
| 2025-07-1520:14 ET | DEF 14A | Proxy statementPeriod 2025-08-29 | 0001104659-25-068095 |
| 2025-06-1320:15 ET | 8-K | 5.08 Item not in the standard list | 0001104659-25-059362 |
| 2025-05-1420:15 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-007759 |
| 2025-05-0720:45 ET | 8-K | 3.01 Delisting notice | 0001104659-25-045598 |
| 2025-05-0521:20 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-044596 |
| 2025-05-0220:20 ET | 8-K | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-044126 |
| 2025-04-3020:17 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001104659-25-042533 |
| 2025-04-2120:40 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-036866 |
| 2025-04-1520:38 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-004843 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.